Related Experiment Video
Updated: May 27, 2025
06:04
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
2.3K
Clinical Features and Management Strategies in Children With Mycoplasma Pneumoniae
Tamara Garcia1, Todd A Florin2, Jan Leonard1
1Department of Pediatrics, Children's Hospital Colorado and University of Colorado, Aurora, CO.
Pediatric Emergency Care
|February 17, 2025
Summary
Mycoplasma pneumoniae (Mp) community-acquired pneumonia (CAP) in children presents similarly to non-Mp CAP but may involve older children. Polymerase chain reaction testing is key for diagnosis, as clinical outcomes are comparable.
Area of Science:
- Pediatric infectious diseases
- Respiratory infections
- Microbiology
Background:
- Mycoplasma pneumoniae (Mp) is a frequent cause of community-acquired pneumonia (CAP) in children.
- Differentiating Mp CAP from other causes clinically is challenging.
Purpose of the Study:
- To compare clinical presentation, management, and outcomes of pediatric Mp CAP versus non-Mp CAP.
- To identify factors distinguishing Mp CAP in children.
Main Methods:
- Prospective multicenter cohort study of children (≥2 months) with CAP.
- Exclusion of children with complex chronic conditions.
- Polymerase chain reaction (PCR) testing for Mp detection.
- Analysis of clinical outcomes including hospitalization, PICU admission, and rehospitalization.
Main Results:
- 38 of 415 children (7.4%) had Mp detected.
- Children with Mp CAP were older and more likely to receive azithromycin or prior antibiotics.
- No statistical differences in symptom prevalence, lab values, or radiographic findings.
- Children with Mp CAP had a 33% shorter hospital stay.
Conclusions:
- Clinical presentation and outcomes for pediatric Mp CAP are similar to non-Mp CAP.
- PCR testing is crucial for accurate Mp CAP diagnosis.
- While symptom duration may be longer, clinical outcomes do not significantly differ.
More Related Videos
Related Concept Videos
01:28Pneumonia IV: Management
287
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
287
01:30Pneumonia V: Nursing management and Prevention
1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
01:30Pneumonia III: Complications and Assessment
146
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
146
01:26COPD: Management Using Bronchodilators and Corticosteroids
173
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
173
01:30Pneumonia I: Introduction
201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
01:24Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139